Report Detail

Request for Sample of this report

Pharma & Healthcare Global Peptide Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2975017
    • |
  • 18 February, 2019
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

In this report, we study the peptide-based drugs.

Scope of the Report:
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
The worldwide market for Peptide Therapeutics is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 39300 million US$ in 2024, from 28500 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Peptide Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection
Oral
Other

Market Segment by Applications, can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptide Therapeutics, with price, sales, revenue and global market share of Peptide Therapeutics in 2017 and 2018.
Chapter 3, the Peptide Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Peptide Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Peptide Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Peptide Therapeutics Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Injection
      • 1.2.2 Oral
      • 1.2.3 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Cancer
      • 1.3.2 Metabolic Disorders
      • 1.3.3 Central Nervous System
      • 1.3.4 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Sanofi
      • 2.1.1 Business Overview
      • 2.1.2 Peptide Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Teva
      • 2.2.1 Business Overview
      • 2.2.2 Peptide Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Novo Nordisk
      • 2.3.1 Business Overview
      • 2.3.2 Peptide Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Takeda
      • 2.4.1 Business Overview
      • 2.4.2 Peptide Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Eli Lilly
      • 2.5.1 Business Overview
      • 2.5.2 Peptide Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 AstraZeneca
      • 2.6.1 Business Overview
      • 2.6.2 Peptide Therapeutics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Novartis
      • 2.7.1 Business Overview
      • 2.7.2 Peptide Therapeutics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Shire
      • 2.8.1 Business Overview
      • 2.8.2 Peptide Therapeutics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 AbbVie
      • 2.9.1 Business Overview
      • 2.9.2 Peptide Therapeutics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Ipsen
      • 2.10.1 Business Overview
      • 2.10.2 Peptide Therapeutics Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Allergan
      • 2.11.1 Business Overview
      • 2.11.2 Peptide Therapeutics Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Ferring
      • 2.12.1 Business Overview
      • 2.12.2 Peptide Therapeutics Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Merck
      • 2.13.1 Business Overview
      • 2.13.2 Peptide Therapeutics Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 The Medicines
      • 2.14.1 Business Overview
      • 2.14.2 Peptide Therapeutics Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Roche
      • 2.15.1 Business Overview
      • 2.15.2 Peptide Therapeutics Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 J & J
      • 2.16.1 Business Overview
      • 2.16.2 Peptide Therapeutics Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Peptide Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Peptide Therapeutics Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Peptide Therapeutics Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Peptide Therapeutics Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Peptide Therapeutics Market Analysis by Regions

    • 4.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Peptide Therapeutics Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 4.3 Europe Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 4.5 South America Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Peptide Therapeutics Sales and Growth Rate (2014-2019)

    5 North America Peptide Therapeutics by Country

    • 5.1 North America Peptide Therapeutics Sales, Revenue and Market Share by Country
      • 5.1.1 North America Peptide Therapeutics Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Peptide Therapeutics Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 5.3 Canada Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Peptide Therapeutics Sales and Growth Rate (2014-2019)

    6 Europe Peptide Therapeutics by Country

    • 6.1 Europe Peptide Therapeutics Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Peptide Therapeutics Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Peptide Therapeutics Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 6.3 UK Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 6.4 France Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 6.5 Russia Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 6.6 Italy Peptide Therapeutics Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Peptide Therapeutics by Country

    • 7.1 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Peptide Therapeutics Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Country (2014-2019)
    • 7.2 China Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 7.3 Japan Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 7.4 Korea Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 7.5 India Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Peptide Therapeutics Sales and Growth Rate (2014-2019)

    8 South America Peptide Therapeutics by Country

    • 8.1 South America Peptide Therapeutics Sales, Revenue and Market Share by Country
      • 8.1.1 South America Peptide Therapeutics Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Peptide Therapeutics Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Peptide Therapeutics Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Peptide Therapeutics by Countries

    • 9.1 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Peptide Therapeutics Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Peptide Therapeutics Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Peptide Therapeutics Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Peptide Therapeutics Sales and Growth Rate (2014-2019)

    10 Global Peptide Therapeutics Market Segment by Type

    • 10.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Peptide Therapeutics Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Peptide Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Injection Sales Growth and Price
      • 10.2.1 Global Injection Sales Growth (2014-2019)
      • 10.2.2 Global Injection Price (2014-2019)
    • 10.3 Oral Sales Growth and Price
      • 10.3.1 Global Oral Sales Growth (2014-2019)
      • 10.3.2 Global Oral Price (2014-2019)
    • 10.4 Other Sales Growth and Price
      • 10.4.1 Global Other Sales Growth (2014-2019)
      • 10.4.2 Global Other Price (2014-2019)

    11 Global Peptide Therapeutics Market Segment by Application

    • 11.1 Global Peptide Therapeutics Sales Market Share by Application (2014-2019)
    • 11.2 Cancer Sales Growth (2014-2019)
    • 11.3 Metabolic Disorders Sales Growth (2014-2019)
    • 11.4 Central Nervous System Sales Growth (2014-2019)
    • 11.5 Other Sales Growth (2014-2019)

    12 Peptide Therapeutics Market Forecast (2019-2024)

    • 12.1 Global Peptide Therapeutics Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Peptide Therapeutics Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Peptide Therapeutics Market Forecast (2019-2024)
      • 12.2.2 Europe Peptide Therapeutics Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Peptide Therapeutics Market Forecast (2019-2024)
      • 12.2.4 South America Peptide Therapeutics Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Peptide Therapeutics Market Forecast (2019-2024)
    • 12.3 Peptide Therapeutics Market Forecast by Type (2019-2024)
      • 12.3.1 Global Peptide Therapeutics Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Peptide Therapeutics Market Share Forecast by Type (2019-2024)
    • 12.4 Peptide Therapeutics Market Forecast by Application (2019-2024)
      • 12.4.1 Global Peptide Therapeutics Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Peptide Therapeutics Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Peptide Therapeutics . Industry analysis & Market Report on Peptide Therapeutics is a syndicated market report, published as Global Peptide Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Peptide Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,236.40
      		4,854.60
      		6,472.80
      		532,022.40
      		798,033.60
      		1,064,044.80
      		290,336.40
      		435,504.60
      		580,672.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo